1.Proportions of non-matching fund by local governments and central government subsidies in local government health budget: focused on 2020 Jeju Self-Governing Province Budget
Hyeyoung YOO ; Ji Woon JEONG ; Hyeung-Keun PARK
Journal of Agricultural Medicine & Community Health 2021;46(4):266-279
Objectives:
The purpose of the study was to classify the health and medical service affairs of local governments, and to analyze the proportions of non-matching fund by local governments and central government subsidies for local government health budget.
Methods:
First of all, health affairs of local governments were classified to categories based on health-related laws and previous studies by review of the authors. In order to specify the scale of local government-led health affairs, we allocated 1,916 budget units into 6 main and 24 sub categories of the health and medical service affairs of local governments for the 2020 health budget of Jeju Special Self-Governing Province. For each categories, we compared the total amounts and the percentages of the 'central government subsidies', 'local government budget - matching fund', and 'local government budget -non-matching fund'.
Results:
The total health budget of Jeju Special Self-Governing Province accounts for 1.2% of the total budget. Of the total health budget of Jeju Special Self-Governing Province, the proportion of central government subsidies was 39.6% and the proportions of local government budget-matching fund and non-matching fund were 33.8% and 26.6%, respectively. The proportions of non-matching fund by provincial and basic local governments were 37.3% and 19.9%, respectively.
Conclusion
In order for local governments to deal with the health problems of residents, it is necessary to secure and spend more local government budget(i.e., non-matching fund by local government) for health affairs in their administrative jurisdiction.
2.The Emerging Threat of Micro- and Nanoplastics on the Maturation and Activity of Immune Cells
Kang-Bin DAN ; Ji Yoon YOO ; Hyeyoung MIN
Biomolecules & Therapeutics 2025;33(1):95-105
With the increasing use of plastics worldwide, the amount of plastic waste being discarded has also risen. This plastic waste undergoes physical and chemical processes, breaking down into smaller particles known as microplastics (MPs) or nanoplastics (NPs). Advances in technology have enhanced our ability to detect these smaller particles, and it has been confirmed that plastics can be found in marine organisms as well as within the human body. However, research on the effects of MPs or NPs on living organisms has only recently been started, and our understanding remains limited. Studies on the immunological impacts are still ongoing, revealing that MPs and NPs can differentially affect various immune cells based on the material, size, and shape of the plastic particles. In this review, we aim to provide a comprehensive understanding of the effects of MPs and NPs on the immune system. We will also explore the methods for plastic removal through physicochemical, microbial, or biological means.
3.The Emerging Threat of Micro- and Nanoplastics on the Maturation and Activity of Immune Cells
Kang-Bin DAN ; Ji Yoon YOO ; Hyeyoung MIN
Biomolecules & Therapeutics 2025;33(1):95-105
With the increasing use of plastics worldwide, the amount of plastic waste being discarded has also risen. This plastic waste undergoes physical and chemical processes, breaking down into smaller particles known as microplastics (MPs) or nanoplastics (NPs). Advances in technology have enhanced our ability to detect these smaller particles, and it has been confirmed that plastics can be found in marine organisms as well as within the human body. However, research on the effects of MPs or NPs on living organisms has only recently been started, and our understanding remains limited. Studies on the immunological impacts are still ongoing, revealing that MPs and NPs can differentially affect various immune cells based on the material, size, and shape of the plastic particles. In this review, we aim to provide a comprehensive understanding of the effects of MPs and NPs on the immune system. We will also explore the methods for plastic removal through physicochemical, microbial, or biological means.
4.The Emerging Threat of Micro- and Nanoplastics on the Maturation and Activity of Immune Cells
Kang-Bin DAN ; Ji Yoon YOO ; Hyeyoung MIN
Biomolecules & Therapeutics 2025;33(1):95-105
With the increasing use of plastics worldwide, the amount of plastic waste being discarded has also risen. This plastic waste undergoes physical and chemical processes, breaking down into smaller particles known as microplastics (MPs) or nanoplastics (NPs). Advances in technology have enhanced our ability to detect these smaller particles, and it has been confirmed that plastics can be found in marine organisms as well as within the human body. However, research on the effects of MPs or NPs on living organisms has only recently been started, and our understanding remains limited. Studies on the immunological impacts are still ongoing, revealing that MPs and NPs can differentially affect various immune cells based on the material, size, and shape of the plastic particles. In this review, we aim to provide a comprehensive understanding of the effects of MPs and NPs on the immune system. We will also explore the methods for plastic removal through physicochemical, microbial, or biological means.
5.An Unusual Case of Myeloperoxidase-Positive Acute Megakaryoblastic Leukemia.
Hyeyoung LEE ; Yonggoo KIM ; Yoo Jin KIM ; Kyungja HAN
Annals of Laboratory Medicine 2015;35(4):466-468
No abstract available.
Leukemia, Megakaryoblastic, Acute*
6.Docosahexaenoic Acid Inhibits Expression of Fibrotic Mediators in Mice With Chronic Pancreatitis
Sle LEE ; Yoo Kyung JEONG ; Joo Weon LIM ; Hyeyoung KIM
Journal of Cancer Prevention 2019;24(4):233-239
BACKGROUND: Chronic pancreatitis (CP) is an irreversible progressive disease that destroys exocrine parenchyma, which are replaced by fibrous tissue. As pancreatic fibrosis is a key feature of CP, reducing fibrotic protein content in the pancreas is crucial for preventing CP. Studies suggest that NF-κB facilitates the expression of fibrotic mediators in pancreas and protein kinase C-δ (PKC-δ) regulates NF-κB activation in stimulated pancreatic acinar cells. Docosahexaenoic acid (DHA) is an omega-3 fatty acid having anti-inflammatory and anti-fibrotic effects. It has been shown to inhibit NF-κB activity in cerulein-stimulated pancreatic acinar cells which is a cellular model of CP. In the present study, we investigated if DHA inhibits expression of fibrotic mediators by reducing PKC-δ and NF-κB expression in mouse pancreatic tissues with CP.METHODS: For six weeks, mice were weekly induced for acute pancreatitis to develop CP. Furthermore, acute pancreatitis was induced by hourly intraperitoneal injections of cerulein (50 μg/kg × 7). Mice were administered DHA (10 μM) via drinking water before and after CP induction.RESULTS: Cerulein-induced pancreatic damages like decreased pancreatic weight/total body weight, leukocyte infiltration, necrosis of acinar cells, and vacuolization were found to be inhibited by DHA. Additionally, DHA inhibited cerulein-induced fibrotic mediators like alpha-smooth muscle actin and fibronectin in pancreas. DHA reduced expression of PKC-δ and NF-κB p65 in pancreatic tissues of cerulein-treated mice.CONCLUSIONS: DHA may be beneficial in preventing CP by suppressing pancreatic expression of fibrotic mediators.
Acinar Cells
;
Actins
;
Animals
;
Body Weight
;
Ceruletide
;
Drinking Water
;
Fibronectins
;
Fibrosis
;
Injections, Intraperitoneal
;
Leukocytes
;
Mice
;
Necrosis
;
Pancreas
;
Pancreatitis
;
Pancreatitis, Chronic
;
Protein Kinases
7.Parry-Romberg Syndrome Augmented by Hyaluronic Acid Filler.
Mingyul JO ; Hyosang AHN ; Hyeyoung JU ; Eunjung PARK ; Jisook YOO ; Min Soo KIM ; Mihn Sook JUE ; Kwanghyun CHOI
Annals of Dermatology 2018;30(6):704-707
Parry Romberg Syndrome (PRS), also known as idiopathic progressive hemifacial atrophy, is a rare neurocutaneous disorder characterized by loss of skin and subcutaneous fat of face, muscles, and bones causing unilateral atrophy. Most patients require only soft tissue augmentation although syndrome has varying grades of severity. In the majority of reported cases, it has been treated with surgical flap or autologous fat transplantation. However, these treatments need complicated surgical skills which take a lot of time and cost. Herein we report the first case of PRS augmented by hyaluronic acid (HA) filler in a 42-year-old female patient to suggest that HA filler could be a safe, simple, and even rational economic alternative to surgical treatment.
Adult
;
Atrophy
;
Facial Hemiatrophy*
;
Female
;
Humans
;
Hyaluronic Acid*
;
Muscles
;
Neurocutaneous Syndromes
;
Skin
;
Subcutaneous Fat
;
Surgical Flaps
8.Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?.
Byung Cheol SONG ; Yoo Kyung CHO ; Hyeyoung JWA ; Eun Kwang CHOI ; Heung Up KIM ; Hyun Joo SONG ; Soo Young NA ; Sun Jin BOO ; Seung Uk JEONG
Clinical and Molecular Hepatology 2014;20(4):355-360
BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed twice the upper limit of normal (ULN). However, HBeAg seroconversion occurs infrequently in patients infected with hepatitis B virus (HBV) genotype C. The aim of the present study was to determine whether the waiting policy is necessary in endemic areas of HBV genotype C infection. METHODS: Ninety patients with HBeAg-positive CHB were followed prospectively without administering antiviral therapy for 6 months. Antiviral therapy was initiated promptly at any time if there was any evidence of biochemical (i.e., acute exacerbation of HBV infection or aggravation of jaundice) or symptomatic deterioration. After 6 months of observation, antiviral therapy was initiated according to the patient's ALT and HBV DNA levels. RESULTS: Only one patient (1.1%) achieved spontaneous HBeAg seroconversion. Biochemical and symptomatic deterioration occurred before 6 months in 17 patients (18.9%) and 5 patients, respectively. High ALT and HBV DNA levels were both independent risk factors for biochemical deterioration. Of 15 patients with HBV DNA > or =5.1x107 IU/mL and ALT > or =5xULN, biochemical deterioration occurred in 7 (46.7%), including 1 patient receiving liver transplantation due to liver failure. CONCLUSIONS: Spontaneous HBeAg seroconversion in patients with HBeAg-positive CHB is rare within 6 months. Biochemical deterioration was common and may lead to liver failure. Immediate antiviral therapy should be considered, especially in patients with high ALT and HBV DNA levels in endemic areas of genotype C infection.
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/*therapeutic use
;
DNA, Viral/blood
;
Female
;
Follow-Up Studies
;
Genotype
;
Guanine/analogs & derivatives/therapeutic use
;
Hepatitis B e Antigens/*blood
;
Hepatitis B virus/*genetics
;
Hepatitis B, Chronic/*drug therapy
;
Humans
;
Male
;
Middle Aged
;
Prospective Studies
;
Risk Factors
9.Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging.
Youngrok CHOI ; Jeong Min LEE ; Nam Joon YI ; Hyeyoung KIM ; Min Su PARK ; Geun HONG ; Tae YOO ; Suk Won SUH ; Hae Won LEE ; Kwang Woong LEE ; Kyung Suk SUH
Annals of Surgical Treatment and Research 2015;89(1):37-42
PURPOSE: We evaluated the heterogeneity of steatosis in living donor livers to determine its regional differences. METHODS: Between June 2011 and February 2012, 81 liver donors were selected. Fat fraction was estimated using magnetic resonance triple-echo chemical shifting gradient imaging in 13 different regions: segment 1 (S1), S2, S3, and each peripheral and deep region of S4, S5, S6, S7, and S8. RESULTS: There were differences (range, 3.2%-5.3%) in fat fractions between each peripheral and deep region of S4, S6, S7, and S8 (P < 0.001, P = 0.004, P < 0.001, and P = 0.006). Fat deposit amount in S1, S2, S3 and deep regions of S4-S8 were significantly different from one another (F [4.003, 58.032] = 8.684, P < 0.001), while there were no differences among the peripheral regions of S4-S8 (F [2.9, 5.3] = 1.3, P = 0.272) by repeated measure analysis of variance method. And regional differences of the amount of fat deposit in the whole liver increased as a peripheral fat fraction of S5 increased (R2 = 0.428, P < 0.001). CONCLUSION: Multifocal fat measurements for the whole liver are needed because a small regional evaluation might not represent the remaining liver completely, especially in patients with severe hepatic steatosis.
Fatty Liver
;
Humans
;
Liver
;
Liver Transplantation
;
Living Donors*
;
Magnetic Resonance Imaging*
;
Population Characteristics
;
Tissue Donors
;
Transplant Donor Site
10.Status and Current Problems in the Allocation System for Pediatric Liver Transplantation in Korea.
Youngrok CHOI ; Kwang Woong LEE ; Geun HONG ; Hyeyoung KIM ; Min Su PARK ; Sukwon SUH ; Tae YOO ; Hae Won LEE ; Nam Joon YI ; Kyung Suk SUH
The Journal of the Korean Society for Transplantation 2012;26(3):196-201
BACKGROUND: The aim of this study was to investigate the current status and identify any existing problems in the allocation system of liver transplantation (LT) for children in Korea. METHODS: The information for the period between January 2006 and March 2012 contained in the Korean Network for Organ Sharing (KONOS) database, and the 2008 and 2010 annual reports from KONOS were analyzed. Detailed information about split LT (SLT) was analyzed using the SLT database which contains data collected since 2010. RESULTS: Of 4,462 cases of LT between January 2006 and December 2010, 243 were pediatric cases (5.4%). Of these pediatric cases, 195 (80.2%) were living donor LT. Of the liver grafts from deceased pediatric donors, 68% were donated to adults and 3.9% were shared with children. Of the 104 splittable donors from January 2010 to March 2012, a split was performed only in 4.6% of cases. The main reason for the low split rate was few pediatric candidate(s) in the waiting list due to strict Korean regulatory requirements for split candidate registration. CONCLUSIONS: Under the current liver transplant allocation system, Korean children have less chance to receive a liver graft from a deceased donor. With improvement of the allocation system and the rules governing SLT, children in need may have greater opportunity to receive a deceased donor graft without negatively affecting adult recipients.
Adult
;
Child
;
Humans
;
Korea
;
Liver
;
Liver Transplantation
;
Living Donors
;
Tissue Donors
;
Transplants
;
Waiting Lists